Concurrent Systemic Chemoimmunotherapy and Sofosbuvir-Based Antiviral Treatment in a Hepatitis C Virus-Infected Patient With Diffuse Large B-Cell Lymphoma

Hepatitis C virus (HCV) infection is associated with the development of non-Hodgkin lymphomas. For aggressive lymphomas, such as diffuse large B-cell lymphoma (DLBCL), treatment of HCV infection is typically deferred in treatment-naive patients until after completion of lymphoma therapy [1, 2]. We r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ewers, Evan C., Shah, Phalgoon A., Carmichael, Mark G., Ferguson, Tomas M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Id Cases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5170491/
https://www.ncbi.nlm.nih.gov/pubmed/28018926
http://dx.doi.org/10.1093/ofid/ofw223
_version_ 1782483768706072576
author Ewers, Evan C.
Shah, Phalgoon A.
Carmichael, Mark G.
Ferguson, Tomas M.
author_facet Ewers, Evan C.
Shah, Phalgoon A.
Carmichael, Mark G.
Ferguson, Tomas M.
author_sort Ewers, Evan C.
collection PubMed
description Hepatitis C virus (HCV) infection is associated with the development of non-Hodgkin lymphomas. For aggressive lymphomas, such as diffuse large B-cell lymphoma (DLBCL), treatment of HCV infection is typically deferred in treatment-naive patients until after completion of lymphoma therapy [1, 2]. We report a case of HCV-associated stage IV DLBCL successfully treated concurrently using chemoimmunotherapy and a sofosbuvir-based antiviral regimen.
format Online
Article
Text
id pubmed-5170491
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-51704912016-12-23 Concurrent Systemic Chemoimmunotherapy and Sofosbuvir-Based Antiviral Treatment in a Hepatitis C Virus-Infected Patient With Diffuse Large B-Cell Lymphoma Ewers, Evan C. Shah, Phalgoon A. Carmichael, Mark G. Ferguson, Tomas M. Open Forum Infect Dis Id Cases Hepatitis C virus (HCV) infection is associated with the development of non-Hodgkin lymphomas. For aggressive lymphomas, such as diffuse large B-cell lymphoma (DLBCL), treatment of HCV infection is typically deferred in treatment-naive patients until after completion of lymphoma therapy [1, 2]. We report a case of HCV-associated stage IV DLBCL successfully treated concurrently using chemoimmunotherapy and a sofosbuvir-based antiviral regimen. Oxford University Press 2016-12-20 /pmc/articles/PMC5170491/ /pubmed/28018926 http://dx.doi.org/10.1093/ofid/ofw223 Text en Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.
spellingShingle Id Cases
Ewers, Evan C.
Shah, Phalgoon A.
Carmichael, Mark G.
Ferguson, Tomas M.
Concurrent Systemic Chemoimmunotherapy and Sofosbuvir-Based Antiviral Treatment in a Hepatitis C Virus-Infected Patient With Diffuse Large B-Cell Lymphoma
title Concurrent Systemic Chemoimmunotherapy and Sofosbuvir-Based Antiviral Treatment in a Hepatitis C Virus-Infected Patient With Diffuse Large B-Cell Lymphoma
title_full Concurrent Systemic Chemoimmunotherapy and Sofosbuvir-Based Antiviral Treatment in a Hepatitis C Virus-Infected Patient With Diffuse Large B-Cell Lymphoma
title_fullStr Concurrent Systemic Chemoimmunotherapy and Sofosbuvir-Based Antiviral Treatment in a Hepatitis C Virus-Infected Patient With Diffuse Large B-Cell Lymphoma
title_full_unstemmed Concurrent Systemic Chemoimmunotherapy and Sofosbuvir-Based Antiviral Treatment in a Hepatitis C Virus-Infected Patient With Diffuse Large B-Cell Lymphoma
title_short Concurrent Systemic Chemoimmunotherapy and Sofosbuvir-Based Antiviral Treatment in a Hepatitis C Virus-Infected Patient With Diffuse Large B-Cell Lymphoma
title_sort concurrent systemic chemoimmunotherapy and sofosbuvir-based antiviral treatment in a hepatitis c virus-infected patient with diffuse large b-cell lymphoma
topic Id Cases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5170491/
https://www.ncbi.nlm.nih.gov/pubmed/28018926
http://dx.doi.org/10.1093/ofid/ofw223
work_keys_str_mv AT ewersevanc concurrentsystemicchemoimmunotherapyandsofosbuvirbasedantiviraltreatmentinahepatitiscvirusinfectedpatientwithdiffuselargebcelllymphoma
AT shahphalgoona concurrentsystemicchemoimmunotherapyandsofosbuvirbasedantiviraltreatmentinahepatitiscvirusinfectedpatientwithdiffuselargebcelllymphoma
AT carmichaelmarkg concurrentsystemicchemoimmunotherapyandsofosbuvirbasedantiviraltreatmentinahepatitiscvirusinfectedpatientwithdiffuselargebcelllymphoma
AT fergusontomasm concurrentsystemicchemoimmunotherapyandsofosbuvirbasedantiviraltreatmentinahepatitiscvirusinfectedpatientwithdiffuselargebcelllymphoma

Ejemplares similares